AbbVie Sees Higher Earnings on Strong Humira Sales; Beats Estimates (ABBV)

From The Dividend Daily
April 26, 2013 - 10:19am

Pharmaceutical company, AbbVie Inc (ABBV) reported increased profits for its first quarter on Friday, which were helped by strong sales for its arthritis drug, Humira. The North Chicago, IL based company reported first quarter earnings of $968 million, or 60 cents per share, up 9% from $883 million, or 56 cents per share last year. [...]


Share this article »  

Continue reading this article »